Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases

被引:158
作者
Santini, F [1 ]
Pinchera, A [1 ]
Marsili, A [1 ]
Ceccarini, G [1 ]
Castagna, MG [1 ]
Valeriano, R [1 ]
Giannetti, M [1 ]
Taddei, D [1 ]
Centoni, R [1 ]
Scartabelli, G [1 ]
Rago, T [1 ]
Mammoli, C [1 ]
Elisei, R [1 ]
Vitti, P [1 ]
机构
[1] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
D O I
10.1210/jc.2004-1306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Total body weight is usually employed to calculate the amount of L-T(4) to be administered in patients with thyroid diseases. The aim of this study was to evaluate the effect of body composition on L-T(4) requirements. Body composition was assessed by dual energy x-ray absorptiometry in 75 patients on TSH-suppressive L-T(4) therapy after conventional thyroid ablation for differentiated cancer. The mean daily dose of L-T(4) was lower in normal-weight (127.5 +/- 21.3 mug/d) vs. overweight (139.4 +/- 24.5) and obese (151.3 +/- 29.1) subjects. There was a much stronger association between the L-T(4) dosage and lean body mass (P < 0.001, r =0.667) compared with fat mass (P = 0.023, r = .26). Measurement of regional tissue composition showed peripheral lean mass as the best correlate with the dose of L-T(4) (r =0.679, P < 0.001) whereas no correlation was observed with peripheral fat mass. In conclusion, individual L-T(4) requirements are dependent on lean body mass. Age- and gender-related differences in L-T(4) needs reflect different proportions of lean mass over the total body weight. An estimate of lean mass may be helpful to shorten the time required to attain a stable dose of L-T(4), particularly in subjects with high body mass index values that may be due either to increased muscular mass or to obesity.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 32 条
[1]   Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism [J].
Alexander, EK ;
Marqusee, E ;
Lawrence, J ;
Jarolim, P ;
Fischer, GA ;
Larsen, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :241-249
[2]  
BARTALENA L, 1994, ACTA MED AUST, V21, P60
[3]   Segmental body composition assessed by bioelectrical impedance analysis and DEXA in humans [J].
Bracco, D ;
Thiebaud, D ;
Chiolero, RL ;
Landry, M ;
Burckhardt, P ;
Schutz, Y .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (06) :2580-2587
[4]   LEVOTHYROXINE DOSE REQUIREMENTS FOR THYROTROPIN SUPPRESSION IN THE TREATMENT OF DIFFERENTIATED THYROID-CANCER [J].
BURMEISTER, LA ;
GOUMAZ, MO ;
MARIASH, CN ;
OPPENHEIMER, JH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :344-350
[5]   LEAN BODY-MASS IS A PREDICTOR OF THE DAILY REQUIREMENT FOR THYROID-HORMONE IN OLDER MEN AND WOMEN [J].
CUNNINGHAM, JJ ;
BARZEL, US .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1984, 32 (03) :204-207
[6]   SERUM TSH CONCENTRATION AS AN AID TO MONITORING COMPLIANCE WITH THYROID-HORMONE THERAPY IN HYPOTHYROIDISM [J].
ENGLAND, ML ;
HERSHMAN, JM .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1986, 292 (05) :264-266
[7]   Effects of thyroid hormone on the cardiovascular system [J].
Fazio, S ;
Palmieri, EA ;
Lombardi, G ;
Biondi, B .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 :31-50
[8]   REPLACEMENT DOSE, METABOLISM, AND BIOAVAILABILITY OF LEVOTHYROXINE IN THE TREATMENT OF HYPOTHYROIDISM - ROLE OF TRIIODOTHYRONINE IN PITUITARY FEEDBACK IN HUMANS [J].
FISH, LH ;
SCHWARTZ, HL ;
CAVANAUGH, J ;
STEFFES, MW ;
BANTLE, JP ;
OPPENHEIMER, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) :764-770
[9]   COMPARISON OF 2ND AND 3RD GENERATION METHODS FOR MEASUREMENT OF SERUM THYROTROPIN IN PATIENTS WITH OVERT HYPERTHYROIDISM, PATIENTS RECEIVING THYROXINE THERAPY, AND THOSE WITH NONTHYROIDAL ILLNESS [J].
FRANKLYN, JA ;
BLACK, EG ;
BETTERIDGE, J ;
SHEPPARD, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1368-1371
[10]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770